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Abstract
Background: Podocyte apoptosis is a major mechanism that leads to proteinuria in many kidney diseases.
However, the concert mechanisms that cause podocyte apoptosis in these kidney diseases are not fully understood.
RhoA is one of Rho GTPases that has been well studied and plays a key role in regulating cytoskeletal architecture.
Previous study showed that insufficient RhoA could result in rat aortic smooth muscle cell apoptosis. However,
whether RhoA is involved in podocyte apoptosis remains unknown.
Methods: Culture podocytes were treated with LPS, ADR or siRNA for 48 h before harvest. Subcellular
immunoblotting, qRT-PCR, immunofluorescence and flow cytometry were used to exam the expression and
function of RhoA or YAP in podocytes.
Results: We found that the expression of RhoA and its activity were significantly decreased in LPS or ADR-injured
podocytes, accompanying loss of stress fibers and increased cell apoptosis. Knocking down RhoA or its downstream
effector mDia expression by siRNA also caused loss of stress fibers and podocyte apoptosis. Moreover, our results
further demonstrated that RhoA deficiency could reduce the mRNA and protein expression of YAP, which had been
regarded as an anti-apoptosis protein in podocyte. Silenced dendrin expression significantly abolished RhoA, mDia
or YAP deficiency-induced podocyte apoptosis.
Conclusion: RhoA deficiency could disrupt podocyte cytoskeleton and induce podocyte apoptosis by inhibiting
YAP/dendrin signal. RhoA/mDia/YAP/dendrin signal pathway may potentially play an important role in regulating
podocyte apoptosis. Maintaining necessary RhoA would be one potent way to prevent proteinuria kidney diseases.
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Background
Podocytes are highly differentiated cells with complex
actin cytoskeletal architecture that play a key role in
maintaining the integrity of glomerular filtration barrier,
which is crucial for normal glomerular function [1–3].
Therefore, loss of podocytes will surely disturb the func-
tion of glomerular. Apoptosis is one of the main reasons
that causes loss of podocyte and sequentially induces
proteinuria. Accumulating evidences show that podocyte
apoptosis is one of the most important mechanisms in
the pathogenesis of many kidney diseases, such as
chronic kidney disease [4, 5], diabetic nephropathy [6–
8], focal segmental glomerular sclerosis [9, 10], et al.
Thus, preventing podocyte apoptosis will be a promising
therapeutic target for treating these kidney diseases.
However, the concert mechanisms that cause podocyte
apoptosis in these kidney diseases are still far from being
fully understood.
It has been well known that severe disorders of the kid-
ney that present with proteinuria are associated with re-
markable cytoskeletal injury and foot process effacement
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[11]. The function of cytoskeletal architecture is mainly
regulated by small GTPases belonging to the Rho GTPase
family [12, 13]. Ras homolog gene family, member A
(RhoA) is one of Rho GTPases that has been well studied.
Active RhoA binds to its downstream effector mammalian
diaphanous-related formins (mDias) to relieve mDias’
autoinhibition of the DID/DAD interaction and activates
it, thereby promotes stress fibers formation [14, 15]. A
baseline activity of RhoA is essential for the normal func-
tion of glomerular podoctyes, podocytes deficiency in
RhoA will lead to loss of stress fibers and proteinuria [16,
17]. Accumulating evidences have showed that RhoA defi-
ciency could result in cell apoptosis [11, 18], maybe by de-
creasing Yes-associated protein (YAP) expression in both
A549 and HepG2 cells [19].
YAP is a major downstream cascade of the Hippo
pathway which controls the expression of genes that
promote cell proliferation and inhibit apoptosis [20, 21].
Under normal condition, dephosphorylated YAP local-
izes in the nucleus and functions as a transcriptional co-
activator that mainly through interacting with TEA do-
main family member (TEAD) family transcriptional fac-
tors to induce target gene expression [22]. YAP
phosphorylation promotes its cytoplasmic sequestration
and inactivation [23, 24]. As loss of stress fibers caused
by insufficient RhoA can result in reducing transcrip-
tional activity and nuclear localization of YAP [19, 25,
26], which has been regarded as an anti-apoptosis pro-
tein in many kinds of cells [20, 27–29], including podo-
cyte [30, 31], it is likely that RhoA deficiency may induce
podocyte apoptosis by reducing nuclear YAP.
Dendrin is a PPXY motif containing dual compart-
ment protein [32]. It was originally identified in sleep-
deprived rats [33], and also detected in human kidney
podocytes [34]. Ablation of the podocyte death-
promoting protein dendrin can delay onset and severity
of podocytes loss and proteinuria [35]. In normal podo-
cytes, dendrin is a constituent of the glomerular slit dia-
phragm, where it binds to nephrin and CD2-associated
protein [32]. In response to glomerular injury, dendrin
relocates to the podocyte nucleus, thereby promoting
cell apoptosis [36]. Previous study [30] showed that YAP
can bind to dendrin in podocyte nuclei, thereby acting
as an endogenous inhibitor of proapoptotic dendrin sig-
naling in podocytes. Thus, it is possible that RhoA defi-
ciency can induce podocyte apoptosis by inhibiting YAP/
dendrin signal.
In this study, lipopolysaccharide (LPS) or adriamycin
(ADR) was used to elicit podocyte cytoskeleton disrup-
tion and apoptosis, as described previously [9, 37], then
we surprisingly found that RhoA expression and its ac-
tivity were decreased in LPS or ADR injured podocytes.
Previous studies have showed that insufficient RhoA
could result in cell apoptosis [18, 19]. Thus, the aim of
this study is to test whether RhoA deficiency could in-
duce podocyte apoptosis and explore its mechanism,
which may be one common reason that causes protein-
uria in many kidney diseases.
Methods
Cell culture and treatment
The conditionally immortalized mouse podocyte cell line
(MPC) was a kind gift from Dr. Jochen Reiser (Rush
University Medical Center, Chicago, IL, USA), and cul-
tured as described previously [38]. Cells were cultured at
33 °C in RPMI-1640 medium (Gibco BRL, Gaithersburg,
MD, USA) supplemented with 10 % fetal bovine serum
(FBS, Gibco BRL, USA) and recombinant IFN-γ (growth
permissive conditions; CYT-358, ProSpec, Tany Techno-
gene Ltd, Israel). To induce differentiation, podocytes
were reseeded and cultured at 37 °C in 100 cm2 culture
dish coated with 12 mg/ml type-I collagen (BD Bio-
science, Bedford, MA, USA) and in RPMI-1640 medium
supplemented with 5 % FBS, deprived of IFN-γ(growth
restrictive conditions) for 10 to 13 days. After differenti-
ation, podocytes was confirmed by the identification of
synaptopodin, a podocyte differentiation marker, 106cells
were synchronized into quiescence by growing cells in
serum-free RPMI-1640 medium for 24 h, and then
treated with LPS (100 μg/ml), ADR (0.125 μg/ml) or
small interfering RNA (siRNA, 50nM) for 48 h. Each re-
action was repeated in triplicates.
Transfection
The siRNAs against RhoA, mDia, YAP, dendrin and control
were designed and synthesized by RIBOBIO CO., LTD.
(Guangzhou, China), and were transfect into podocytes
using Lipofectamine 2000 reagent (Invitrogen, Carlsbad,
CA) following the manufacturer’s protocol. The sequences
of siRNAs used in this study were as follows: RhoA-siRNA
5′-GGUAAGACAUGCUUGCUCA dTdT-3′, mDia-siRN
A 5′-GCAAGUUCUUGUCCUCUUU dTdT-3′, YAP-siRN
A 5′-CGAGAUG AGAGCACAGACA dTdT-3′, Dendrin-
siRNA 5′-GGCUCCACCUUCUUAUGAA dTdT-3′.
Immunofluorescence
Podocytes were planted on cover slides in six-well plates.
After subjected to various treatments, differentiated
podocytes were fixed with 4 % paraformaldehyde at
room temperature for 10 min, and then treated with
0.1 % Triton X-100 for 10 min, blocked with 1 % bovine
serum albumin for 20 min at room temperature, and in-
cubated with rabbit anti-YAP (Santa Cruz, USA, 1:250)
overnight at 4 °C. After incubated with the goat anti-
rabbit Alexa Fluor 488 (Cell Signaling Technology, USA,
1:1000) for 1 h at room temperature, podocytes were
stained with phalloidin (Cytoskeleton, USA, 1:500) for
30 min and then with DAPI (Sigma, St Louis, MO) for
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5 min at room temperature. Photomicrographs were
taken with laser confocal microscopy (LCSM, Zeiss KS
400, Postfach, Germany). All images were analyzed by
two investigators blinded to the identity of the samples.
Real-time quantitative-PCR
As described previously [6], RNA samples were prepared
using Trizol RNA isolation system (Invitrogen, Carlsbad,
CA) and reverse transcribed into cDNAs using the Prime-
ScriptTM RT regent Kit following the instructions provided
by the manufacturer ((Takara Bio Inc, Japan), and then
cDNAs were used for real-time PCR analysis by a Planti-
num SYBR Green SuperMix-UDG kit (Takara Bio Inc,
Japan). The primers used are listed as follows: RhoA, for-
ward 5′-AGCTT GTGGTAAGACATGCTTG-3′, reverse
5′-GTGTCCCATAAAGCCAACTCTAC-3′, Bax, forward
5′-CTGGACCATAGGTCGGAGTG-3′, reverse 5′-AATT




Whole and nuclear proteins were prepared as described
previously [6]. An aliquot of cell lysates containing 30 μg
of protein was separated on 10 % sodium dodecyl sul-
fate–polyacrylamide gels, and then transferred to polyvi-
nylidene fluoride membranes (Amersham Biosciences).
After blocked by 5 % skim milk for 1 h at room
temperature, membranes were incubated overnight at 4 °
C with the following primary antibodies: rabbit anti-YAP
(Cell Signaling Technology, USA, 1:1000), rabbit anti-
Histone (Cell Signaling Technology, USA, 1:3000), rabbit
anti-RhoA (Santa Cruz, USA, 1:500), rabbit anti-Bax
(Santa Cruz, USA, 1:500), rabbit anti-GAPDH (Bioworld
Technology, China, 1:10000), rabbit anti-Dia (Santa
Cruz, USA, 1:500), rabbit anti-Dendrin (Santa Cruz,
USA, 1:500). The membranes were then incubated with
anti-rabbit IgG (Jackson Immuno Research, USA, 1:
4000) at room temperature for 1 h. Finally, membranes
were treated with ECL reagents (Pierce Chemical, IN,
USA), followed by exposing to X-ray film (Kodak, USA).
The bands of the resulting autoradiographs were quanti-
fied densitometrically using Bandscan software. Protein
expression was quantified as the ratio of specific band to
Histone (nuclear fractions) or GAPDH.
Annexin V and propidium iodide staining assay
Apoptotic cells in different groups were determined
using an Annexin V/PI apoptosis detection kit according
to manufacturer’s protocol (Nanjing KeyGEN Biotech,
China). Briefly, podocytes were resuspended with bind-
ing buffer followed by incubation with 5 ml of Annexin
V (conjugated with FITC) and 5 ml of PI in the dark for
10 min. Cell fluorescence was then analyzed using a Cell
Lab Quanta™ SC Flow cytometer (Beckman Colter, Inc,
USA). Cells positive for Annexin V-FITC were consid-
ered as apoptosis.
RhoA GTPase activation assay
Active RhoA was measured by G-LISA RhoA Activation
Assay Biochem kit (colorimetric assay, Cytoskeleton,
USA) following the manufacturer’s instruction. And the
signal was measured at 490 nm with a microplate reader
(MRX, Dynatech Laboratories). Total RhoA protein ex-
pression of each group was measured by WB, as de-
scribed above. Results were expressed as fold activity of
stimulated in relation to non-stimulated controls nor-
malized to total RhoA protein content.
Statistical analysis
All values are expressed as mean ± standard deviation
(SD). Statistical analysis was performed using the stat-
istical package SPSS for Windows Ver. 19.0 (SPSS,
Inc., Chicago, IL, USA). Statistical analysis of the data
from multiple groups was performed by analysis of variance
followed by LSD or Bonferonni tests. Comparisons between
two groups were conducted by Student’s t test. P-values
<0.05 were considered significant.
Results
LPS or ADR induced podocyte apoptosis
Previous studies have showed that LPS or ADR could in-
duce podocyte apoptosis [9, 30, 37]. Thus, podocyte
apoptosis model induced by LPS or ADR was used in
our study. Apoptosis was verified by testing cell apop-
tosis rate, the mRNA and protein expression of Bax, a
well recognized indicator of apoptosis [39]. As expected,
results showed that cell apoptosis rates were significantly
increased in LPS or ADR-injured podocytes comparing
to normal controls (P < 0.05). Cell apoptosis rates were
9.30 ± 0.48 %, 16.58 ± 1.96 %, 18.88 ± 0.99 % in control,
LPS and ADR group respectively (Fig. 1a-d). Coincided
with results above, the mRNA and protein expression of
Bax were also significantly increased in LPS or ADR-
injured podocytes comparing to normal controls
(Fig. 1e-g).
RhoA expression and activity were decreased in LPS or
ADR-injured podocytes
Since RhoA plays an important role in regulating
cytoskeletal architecture, we speculate that RhoA
would make response to LPS or ADR-induced podo-
cyte cytoskeletal disruption. As shown in Fig. 2a, c-d,
the mRNA and total protein expression of RhoA were
significantly decreased in LPS or ADR-injured podo-
cytes comparing to normal controls. Similarly, RhoA
activity was also obviously decreased in LPS or ADR
treated podocytes. The percentages of RhoA activity
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were 100 %, 66.35 ± 4.10 %, 44.31 ± 14.96 % in con-
trol, LPS and ADR group respectively (Fig. 2b).
RhoA deficiency induced podocyte apoptosis
Previous studies have showed that RhoA deficiency can
result in A549 and HepG2 cell apoptosis [19]. To ex-
plore the role of decreased RhoA in podocytes, we stud-
ied cell apoptosis in RhoA konckdown podocytes. As
shown in Fig. 3d-f, i, apoptosis was markedly increased
in RhoA knockdown (to an average of 20 %, Fig. 3a)
podocytes compare to siCon (P < 0.05). We also investi-
gated the mRNA and protein expression of Bax, which
was a well recognized indicator of apoptosis. As shown
in Fig. 3j-l, the mRNA and protein expression of Bax
were significantly increased in RhoA silenced podocytes.
These data strongly indicated that RhoA deficiency
could induce podocyte apoptosis.
YAP expression was reduced in LPS or ADR-injured
podocytes
YAP has been regarded as an anti-apoptosis protein in
podocyte [30]. Active YAP localizes in the nucleus and
functions as a transcriptional co-activator to induce tar-
get gene expression [22]. To further explore the under-
lying mechanism of RhoA deficiency-induced podocyte
apoptosis, we next investigated the expression of
Fig 1 LPS or ADR induced podocyte apoptosis. a-d Podocytes were stained with Annexin V/PI for flow cytometry analysis. Cell apoptosis rate was
significantly increased in LPS or ADR treated podocytes comparing to normal controls. e Bax mRNA expression was increased in LPS or ADR
treated podocytes. f-g Bax protein expression was increased in LPS or ADR treated podocytes. Results were expressed as fold Bax of LPS or ADR
group in relation to controls normalized to GAPDH. All data were from at least three independent experiments. * P < 0.05 vs controls
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transcriptional co-activator YAP in LPS or ADR-injured
podocytes. We used confocal miscroscopy to examine
the localization of YAP. Results showed that both nu-
clear and cytoplasmic YAP were obviously reduced in
LPS or ADR treated podocytes comparing to normal
controls (Fig. 4a). Results from Immunoblotting also
showed that both nuclear and total YAP were reduced in
LPS or ADR treated podocytes (Fig. 4b-e). These data
indicated that YAP protein expression was significantly
decreased in LPS or ADR-injured podocytes.
Loss of mDia or YAP induced podocyte apoptosis
Since lost of RhoA induced podocyte apoptosis, we in-
vestigated whether loss of its downstream effector mDia
or YAP could also induce podocyte apoptosis. Here, we
used siRNA to knock down mDia (to an average of
31.7 %, Fig. 3b) or YAP (to an average of 7.3 %, Fig. 3c)
expression in podocytes. As shown in Fig. 3d-i, podocyte
apoptosis rates analyzed by flow cytometer were 8.83 ±
1.07 %, 9.36 ± 1.02 %, 20.26 ± 3.37 %, 21.50 ± 1.76 % in
control, control-siRNA, mDia-siRNA and YAP-siRNA
group respectively. Cell apoptosis rate was significantly
increased in mDia or YAP knockdown podocytes (P <
0.05). In addition, we further found that the mRNA and
protein expression of Bax were also significantly increased
in mDia or YAP knockdown podocytes (Fig. 3j-l). Thus,
these data strongly indicated that mDia or YAP deficiency
could induce podocyte apoptosis.
Loss of RhoA/mDia decreased YAP expression in
podocytes
To further explore the underlying mechanism of RhoA
deficiency-induced podocyte apoptosis, we investigated
the expression of YAP in RhoA or its downstream effector
mDia knockdown podocytes. As shown in Fig. 5a, results
from immunofluorescence demonstrated that both nu-
clear and cytoplasmic YAP protein expression were obvi-
ously decreased in RhoA or mDia knockdown podocytes
comparing to con-siRNA treated podocytes. Similar re-
sults from western blotting to analyze the protein expres-
sion of YAP were also obtained in RhoA or mDia
knockdown podocytes (Fig. 5b-e). These data indicated
that RhoA/mDia could positively regulate YAP expression.
In addition, we investigated the expression of
Phalloidin-stained stress fiber, which had been regarded
as a regulator of YAP [25, 26, 30], in RhoA or mDia si-
lenced podocytes. As shown in Fig. 5a, Phalloidin-
stained stress fibers were obviously decreased in RhoA
or mDia silenced podocytes. This is consistent with
above results that stress fibers were also decreased
(Fig. 4a) in LPS or ADR-injured podocytes. These data
indicated that RhoA/mDia may regulate YAP expression
by stress fiber.
Dendrin mediated RhoA/mDia/YAP deficiency-induced
podocyte apoptosis
Previous study had showed that YAP could bind to den-
drin in podocyte nuclei and inhibit dendrin-mediated
Fig 2 RhoA expression and activity were decreased in LPS or ADR-injured podocytes. a RhoA mRNA expression was decreased in LPS or ADR-
injured podocytes. b RhoA activity was decreased in LPS or ADR injured podocytes. Results were expressed as fold activity of LPS or ADR stimu-
lated group in relation to non-stimulated controls normalized to total RhoA protein content. c-d Total RhoA protein expression was decreased in
LPS or ADR-injured podocytes. All results were expressed as fold RhoA of LPS or ADR group in relation to controls normalized to GAPDH. Data
were from at least three independent experiments. * P < 0.05 vs controls
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Fig 3 (See legend on next page.)
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podocyte apoptosis [30]. Thus, to further explore the
underlying mechanism of RhoA/mDia deficientcy-
induced podocyte apoptosis, we investigated whether si-
lenced the proapoptotic dendrin signaling could block
RhoA/mDia deficientcy-induced podocyte apoptosis. As
shown in Fig. 6, dendrin protein expression was knock-
down to about 35 % in Den-siRNA treated podocytes
(Fig. 6a), podocyte apoptosis rates analyzed by flow cyt-
ometer were 8.09 ± 2.00 %, 18.69 ± 4.24 %, 19.15 ±
3.84 %, 21.50 ± 1.76 %, 8.15 ± 1.83 %, 9.26 ± 2.84 %, 9.13
± 2.46 % in control siRNA, RhoA-siRNA, mDia-siRNA,
YAP-siRNA, Dendrin-siRNA plus RhoA-siRNA,
Dendrin-siRNA plus mDia-siRNA, Dendrin-siRNA plus
YAP-siRNA group respectively (Fig. 6b-i). Cell apoptosis
rate was obviously increased in RhoA, mDia or YAP
knockdown podocytes, however, knocking down dendrin
expression with siRNA significantly abolished RhoA/
mDia/YAP deficiency-induced podocyte apoptosis.
Therefore, these data demonstrated that dendrin medi-
ated RhoA/mDia/YAP deficiency-induced podocyte
apoptosis.
Discussion
Podocytes are very special cells with complex actin cyto-
skeletal architecture that play a pivotal role in maintain-
ing normal glomerular function [1–3]. Loss of podocyte
caused by apoptosis is commonly happened in the
pathogenesis of many kidney diseases, such as chronic
kidney disease [4, 5], diabetic nephropathy [6–8], focal
segmental glomerular sclerosis [9, 10], et al. However,
the mechanism mediating podocyte apoptosis remains
incompletely understood. Therefore, exploring the
(See figure on previous page.)
Fig 3 Loss of RhoA, mDia or YAP induced podocyte apoptosis. a-c Con and Con-siRNA were short for blank control and control siRNA
respectively. RhoA and its downstream effector mDia and YAP protein expression was knockdown to 20 %, 31.7 % and 7.3 % respectively in siRNA
treated podocytes. d-i Podocytes were stained with Annexin V/PI for flow cytometry analysis. Cell apoptosis rate was significantly increased in
RhoA, mDia or YAP knockdown podocytes. j Bax mRNA expression was obviously increased in RhoA, mDia or YAP knockdown podocytes. k-l Bax
protein expression was remarkably increased in RhoA, mDia or YAP knockdown podocytes. Results were expressed as fold Bax of RhoA-siRNA,
mDia-RNA or YAP-siRNA group in relation to con-siRNA group normalized to GAPDH. There is no significant difference between control group
and con-siRNA group. Data were from at least three independent experiments. * P < 0.05 vs con-siRNA group
Fig 4 YAP expression was reduced in LPS or ADR-injured podocytes. a Confocal images of podocytes showing expression of YAP (green),
Phalloidin-stained stress fiber (red) and DAPI-stained nuclei (blue). Compared to controls, nuclear and cytoplasmic YAP and stress fiber were re-
duced in LPS or ADR-injured podocytes. Scale bar = 50 μm. b & d WB results show that nuclear YAP protein expression was reduced in both LPS
and ADR treated podocytes. c & e WB results show that total YAP protein expression was reduced in both LPS and ADR treated podocytes. All
results were expressed as fold YAP of LPS or ADR group in relation to controls normalized to Histone or GAPDH. Data were from at least three
independent experiments. * P < 0.05 vs controls
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mechanisms that cause podocyte apoptosis in these kid-
ney diseases is imperative.
In this study, LPS or ADR was used to induce podo-
cyte cytoskeleton disruption and apoptosis. We found
that RhoA expression and its activity were significantly
decreased in LPS or ADR-injured podocytes. Moreover,
we found podocyte apoptosis was increased in RhoA
knockdown podocytes. We also further demonstrated
that RhoA deficiency could reduce the mRNA and pro-
tein expression of YAP, which had been regarded as an
anti-apoptosis protein in podocyte. Knocking down den-
drin expression with siRNA significantly abolished
RhoA, mDia or YAP deficiency-induced podocyte apop-
tosis. Collectively, these data indicated that RhoA/mDia/
YAP/dendrin signal pathway may potentially play an im-
portant role in regulating podocyte apoptosis (Fig. 7).
RhoA is one of Rho GTPases that has been well stud-
ied and regarded as a main regulator of the function of
cytoskeletal architecture [12, 13]. A baseline activity of
RhoA is essential for the normal function of glomerular
podoctyes, and insufficient RhoA leads to loss of stress
fibers, foot process effacement and proteinuria. In a
traditionally view, a stationary podocyte phenotype re-
flects a stable foot process structure with intact slit dia-
phragms, whereas hypermotility manifests as foot
process effacement in vivo. Stimuli that lead to foot
process effacement commonly cause hypermotility of
cultured podocytes [40] and proteinuria in glomerular
diseases [16]. Therefore, RhoA can prevent proteinuria
by stabilizing the podocyte foot process structure,
whereas inactivation of RhoA will cause hypermotility
and sequentially induces proteinuria. However, in our
Fig 5 YAP expression was reduced in RhoA or mDia knockdown podocytes. a Con and Con-siRNA were short for blank control and control siRNA
respectively. Confocal images of podocytes showing expression of YAP (green), Phalloidin-stained stress fiber (red) and DAPI-stained nuclei (blue).
Compared to con-siRNA, nuclear and cytoplasmic YAP and stress fiber were obviously reduced in RhoA-siRNA or mDia-RNA treated podocytes.
Scale bar = 50 μm. b & d WB results show that nuclear YAP protein expression was reduced in RhoA-siRNA or mDia-RNA treated podocytes. c & e
Total YAP protein expression was reduced in RhoA-siRNA or mDia-RNA treated podocytes. All results were expressed as fold YAP of RhoA-siRNA
or mDia-RNA group in relation to con-siRNA group normalized to Histone or GAPDH. There is no significant difference between control group
and con-siRNA group. Data were from at least three independent experiments. * P < 0.05 vs con-siRNA group
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Fig 6 Dendrin mediated RhoA/mDia/YAP deficiency-induced podocyte apoptosis. a Dendrin protein expression was knockdown to about 35 % in
Den-siRNA treated podocytes. b-i Con-siRNA, Den&RhoA-siRNA, Den&mDia-siRNA, Den&YAP-siRNA were short for control siRNA, Dendrin-siRNA
plus RhoA-siRNA, Dendrin-siRNA plus mDia-siRNA, Dendrin-siRNA plus YAP-siRNA respectively. Podocytes were stained with Annexin V/PI for flow
cytometry analysis. Cell apoptosis rate was obviously increased in RhoA, mDia or YAP knockdown podocytes. Knocking down dendrin expression
with siRNA significantly abolished RhoA, mDia or YAP deficiency-induced podocyte apoptosis. All data were from at least three independent ex-
periments. * P < 0.05 vs con-siRNA group. # P < 0.05
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study, we demonstrated that insufficient RhoA or its
downstream effector mDia [14] could cause podocyte
apoptosis, which was another main reason that would
cause proteinuria. These data indicate that podocyte
apoptosis is probably a new mechanism of proteinuria
induced by RhoA deficiency.
YAP is a major downstream cascade of the Hippo
pathway and dephosphorylated YAP localizes in the nu-
cleus and functions as a transcriptional co-activator to
induce target gene expression in normal condition [22].
It has a well described role in controlling the expression
of genes that promote cell proliferation and inhibit
apoptosis [20, 21]. Evidence had showed that YAP could
also serve as a physiologic inhibitor of podocyte apop-
tosis [30]. This was consistent with our results that
apoptosis was increased in YAP knockdown podocytes.
Our data further demonstrated that YAP expression and
its activity were decreased in RhoA or it downstream ef-
fector mDia knockdown podocytes. Similar results had
also been obtained in A549 cells, HepG2 cells [19] and
mesenchymal stem cells [25] from previous studies.
Therefore, these data indicate that YAP may mediate
RhoA/mDia deficiency-induced podocyte apoptosis.
To further explore the underlying mechanism of
RhoA/mDia deficiency-induced apoptosis, we studied
how RhoA regulate YAP. Previous studies had showed
that RhoA could work through actin cytoskeleton to
promote stress fibers formation, thereby regulated YAP
phosphorylation in Lats1/2 kinase activity dependent
[19, 41–43] or independent [25, 44, 45] pathway. Simi-
larly, in our study we found that podocyte deficiency in
RhoA or mDia could significantly lead to loss of stress
fibers, thereby decreased YAP expression to induce
podocyte apoptosis. Therefore, RhoA/mDia/stress fibers/
YAP may be an important signal pathway to regulate
podocyte apoptosis. And insufficient RhoA/mDia/stress
fibers/YAP pathway activity in podocyte may be one
common reason that causes proteinuria in many kidney
diseases.
Since YAP is known to inhibit dendrin mediated apop-
tosis in podocytes [30], to define if RhoA activation of
YAP could inhibit apoptosis through dendrin, and to
strengthen the connection among RhoA, mDia, YAP
and dendrin in podocytes, we silenced dendrin in RhoA,
mDia or YAP knockdown podocytes and studied if cell
apoptosis could be prevented. As expected, knocking
down dendrin expression with siRNA significantly abol-
ished RhoA, mDia or YAP deficiency-induced podocyte
apoptosis. Thus, these data demonstrate that dendrin
mediates RhoA/mDia/YAP deficiency-induced podocyte
apoptosis.
Taken together, the present study demonstrated that
RhoA expression and its activity were significantly de-
creased while cell apoptosis was increased in LPS or
ADR-injured podocytes. Knocked down RhoA and its
downstream effector mDia expression induced podocyte
apoptosis. Moreover, RhoA deficiency-induced podocyte
apoptosis was probably mediated by reducing YAP ex-
pression, silenced dendrin expression significantly abol-
ished RhoA, mDia or YAP deficiency-induced podocyte
apoptosis. Collectively, our data indicate that RhoA/
mDia/YAP/dendrin signal pathway may potentially play
an important role in regulating podocyte apoptosis.
Conclusions
RhoA/mDia/YAP/dendrin signal pathway may poten-
tially play an important role in regulating podocyte
apoptosis. It may be one common reason that causes
proteinuria in many kidney diseases. Maintaining neces-
sary RhoA would be one potent way to prevent protein-
uria kidney diseases.
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